Thomas Shultzaberger
Director of Engineering & Capital Projects at AmbioPharm - A Global Peptide CDMO | United States
Thomas Shultzaberger’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Director of Engineering & Capital Projects at AmbioPharm - A Global Peptide CDMO in July 2025 - Present
Director, Engineering & Maintenance at Curia in January 2024 - June 2025
Site Director at AmbioPharm - A Global Peptide CDMO in October 2022 - December 2023
Director of Engineering & Facilities at AmbioPharm - A Global Peptide CDMO in January 2021 - September 2023
Sr. Engineering Manager at American Regent, Inc in September 2018 - January 2021
Sr. Engineering Manager at Glenmark Pharmaceuticals in October 2016 - August 2018
Director Of Engineering at Amgen in December 2006 - August 2011
Director Of Engineering at Cardinal Health in April 2002 - November 2006
Clemson University, Bachelor of Science - BS, August 1977 to August 1982
Colorado State University, Master of Business Administration - MBA, August 2026
AmbioPharm is a global custom synthetic peptide CDMO founded in 2005 and headquartered in North Augusta, South Carolina, USA specializing in developing highly efficient manufacturing processes for peptide-based Active Pharmaceutical Ingredients (APIs) at clinical and commercial stages. In our manufacturing facilities in South Carolina, USA and Shanghai, China, we manufacture New Chemical Entities (NCEs) under cGMP for clients worldwide. Both facilities have been inspected multiple times by the FDA as well as other global regulatory bodies with excellent outcomes. Our mission is to accelerate your peptides to patients.
Discover more about AmbioPharm - A Global Peptide CDMO
QC Release Supervisor at Ambiopharm
QC Supervisor at AmbioPharm - A Global Peptide CDMO
(April 2023 – Present)
Analytical Scientist | Quality Control Scientist | Bioanalysis
QC Chemist-II at AmbioPharm - A Global Peptide CDMO
(August 2023 – Present)
Senior Project Manager at AmbioPharm
Senior Project Manager at AmbioPharm - A Global Peptide CDMO
(October 2024 – Present)
Quality Control Chemist III
Quality Control Chemist III at AmbioPharm - A Global Peptide CDMO
(June 2022 – Present)
Analytical Chemist/ Analytical Scientist
QC Chemist II at AmbioPharm - A Global Peptide CDMO
(July 2025 – Present)
Purification Supervisor
Purification Supervisor at AmbioPharm - A Global Peptide CDMO
(November 2021 – Present)
What is Thomas Shultzaberger email address?
Email Thomas Shultzaberger at [email protected]. This email is the most updated Thomas Shultzaberger's email found in 2026.
How to contact Thomas Shultzaberger?
To contact Thomas Shultzaberger send an email to [email protected]. (updated on July 2026)
What company does Thomas Shultzaberger work for?
Thomas Shultzaberger works for AmbioPharm - A Global Peptide CDMO.
What is Thomas Shultzaberger's role at AmbioPharm - A Global Peptide CDMO?
Thomas Shultzaberger is Director of Engineering & Capital Projects
What industry does Thomas Shultzaberger work in?
Thomas Shultzaberger works in the Pharmaceuticals industry.
